Oldest pages

Showing below up to 50 results in range #101 to #150.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Insulin resistance and atherosclerosis‏‎ (15:57, 6 August 2022)
  2. Growth hormone and metabolism‏‎ (15:58, 6 August 2022)
  3. Ole of insulin resistance and hyperglycemia in the development of atherosclerosis‏‎ (15:58, 6 August 2022)
  4. Somatostatin-a regulatory modulator connecting nutrient entry and metabolism‏‎ (15:58, 6 August 2022)
  5. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease an updated review‏‎ (15:58, 6 August 2022)
  6. The effects of cyproterone acetate and ethinyl oestradiol on carbohydrate metabolism‏‎ (15:59, 6 August 2022)
  7. A critical interpretation of experiments of binding of peptide hormone to specific receptors by computer modelling‏‎ (15:59, 6 August 2022)
  8. Genetic influences on glucose neurotoxicity, aging, and diabetes a possible role for glucose hysteresis‏‎ (15:59, 6 August 2022)
  9. Insulin-induced receptor regulation in cultured Zajdela rat hepatoma cells and relationship to the stimulation of glycogen synthesis.‏‎ (15:59, 6 August 2022)
  10. Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp.‏‎ (16:00, 6 August 2022)
  11. An essential role for fibronectin extra type III domain A in pulmonary fibrosis‏‎ (16:00, 6 August 2022)
  12. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma‏‎ (16:00, 6 August 2022)
  13. Epithelialaemesenchymal interactions in pulmonary fibrosis‏‎ (16:01, 6 August 2022)
  14. Mapping of DD1 distribution and oligomerization on the cell surface by FET microscopy‏‎ (16:01, 6 August 2022)
  15. IGF2 overaeexpression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting‏‎ (16:01, 6 August 2022)
  16. Interaction of discoidin domain receptor 1 with collagen type 1‏‎ (16:01, 6 August 2022)
  17. Fibrosis, chronic inflammation and new pathways for drug discovery‏‎ (16:02, 6 August 2022)
  18. Increased serum high mobility group boxae1 level in ChurgaeStrauss syndrome THIS ATICLE HAS BEEN ETACTED‏‎ (16:02, 6 August 2022)
  19. Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis‏‎ (16:02, 6 August 2022)
  20. Experimental models for the study of pulmonary fibrosis current usefulness and future promise‏‎ (16:02, 6 August 2022)
  21. Factorial design analysis of reduction of simulated iron ore sinter reduced with CO gas at 1000ae1100a C‏‎ (16:03, 6 August 2022)
  22. Simulation of austenitic stainless steel oxidation containing nitrogen at temperature range 500 Cae800 C‏‎ (16:03, 6 August 2022)
  23. Physicochemical processing of low grade ferruginous manganese ores‏‎ (16:03, 6 August 2022)
  24. Preliminary Study Of Processing Manganese Ore From Pringsewu District Of Lampung Province‏‎ (16:03, 6 August 2022)
  25. Analysis of the reduction yield of synthetic iron oxide sinter reduced by H‏‎ (16:04, 6 August 2022)
  26. Laser Welding of Coated Press-hardened Steel 22MnB5‏‎ (16:04, 6 August 2022)
  27. Effect of Pulsed Current Gas Tungsten Arc Process on the Dissimilar Weldments between Nickel-based Superalloy/Austenitic Stainless Steel‏‎ (16:04, 6 August 2022)
  28. Evidence-based management of postoperative nausea and vomiting a review‏‎ (16:04, 6 August 2022)
  29. Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy a comparison of tropisetron with saline‏‎ (16:05, 6 August 2022)
  30. A randomized comparison of a multimodal management strategy versus combination antiemetics for the prevention of postoperative nausea and vomiting‏‎ (16:05, 6 August 2022)
  31. Amosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting‏‎ (16:05, 6 August 2022)
  32. The utility of antiemetics in the prevention and treatment of postoperative nausea and vomiting in patients scheduled for laparoscopic cholecystectomy‏‎ (16:05, 6 August 2022)
  33. Comparison of ramosetron with ondansetron for prevention of postoperative nausea and vomiting in patients undergoing gynaecological surgery‏‎ (16:06, 6 August 2022)
  34. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nauseaae‏‎ (16:06, 6 August 2022)
  35. Amosetron versus ondansetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy‏‎ (16:06, 6 August 2022)
  36. Anaesthetic considerations for laparoscopic cholecystectomy‏‎ (16:06, 6 August 2022)
  37. Postoperative nausea and vomiting prevention and therapy‏‎ (16:07, 6 August 2022)
  38. Diagnostic Challenge‏‎ (16:07, 6 August 2022)
  39. Bone marrow stem cell applied in the canine veterinary clinics‏‎ (16:07, 6 August 2022)
  40. Heterogeneous Photocatalytic Discoloration/Degradation of hodamine B with H2O2 and Spinel Copper Ferrite Magnetic Nanoparticles‏‎ (16:07, 6 August 2022)
  41. Kinetics of Ti02 Photocatalytic Decomposition‏‎ (16:08, 6 August 2022)
  42. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting a meta-analysis‏‎ (16:08, 6 August 2022)
  43. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting‏‎ (16:08, 6 August 2022)
  44. Nausea, vomiting, and retching complex problems in palliative care‏‎ (16:09, 6 August 2022)
  45. Dimenhydrinate and metoclopramide alone or in combination for prophylaxis of PONV‏‎ (16:09, 6 August 2022)
  46. Systemic metoclopramide to prevent postoperative nausea and vomiting a meta-analysis without Fujiis studies‏‎ (16:10, 6 August 2022)
  47. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home‏‎ (16:10, 6 August 2022)
  48. Template Polymerization of Aniline in Presence of Poly (acrylamide-co-maleic acid) for Preparation of Conductive Polymers‏‎ (16:11, 6 August 2022)
  49. High-frequency magnetic properties of soft magnetic cores based on nanocrystalline alloy powder prepared by thermal oxidation‏‎ (16:11, 6 August 2022)
  50. High frequency magnetic properties of Feaebased nanocrystalline alloy powder cores‏‎ (16:11, 6 August 2022)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)